Jennifer Nessel, Assistant Editor

The General Pharmaceutical Council has made plans to temporarily re-register pharmacists and pharmacy technicians should the government launch a state of emergency due to the novel coronavirus.

Researchers in Australia tested blood samples at 4 different time points in an otherwise healthy adult woman who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission.

Researchers and senior physicians support a French official’s warning that individuals showing symptoms of the novel coronavirus should use paracetamol rather than ibuprofen.

A new study shows that the advantages of digital breast tomosynthesis are maintained over multiple years and rounds of screening compared with digital mammography.

West Virginia legislature passes a bill that will affect reimbursement for services that fall within a pharmacist’s purview and are ordinarily provided by other health care providers.

Top news from across the health care landscape.

A new executive order from Kentucky Gov. Andy Beshear has expanded prescribing rights to pharmacists in light of the novel coronavirus.

French health officials have warned that widely used OTC anti-inflammatory drugs may worsen the novel coronavirus known as COVID-19, whereas others say more evidence is needed.

In response to growing concern surrounding the novel coronavirus, Cedarville University School of Pharmacy and Cedar Care Village Pharmacy presented an online town hall meeting with an infectious disease expert.

A growth hormone known as insulin-like growth factor-1 has been found to play a role in the development of breast cancer.

The FDA has approved olopatadine hydrochloride ophthalmic 0.1% and 0.2% solution for sale as an OTC medication in the United States.

New research shows targeting stromal cells may be an effective way of overcoming resistance to chemotherapy and radiation in patients with glioblastoma, a deadly brain cancer.

A bipartisan coalition in Congress has introduced new legislation designed to ensure Medicare patients have access to Part B home infusion medications.

The FDA has approved nivolumab plus ipilimumab injections for intravenous use to treat hepatocellular carcinoma in patients who have been previously treated with sorafenib.

The Centers for Medicare & Medicaid Services has issued key protective mask guidance for health care workers following the recent CDC and FDA statements regarding the novel coronavirus 2019.

Understanding the financial side of the business is an important part of owning a pharmacy, as such having knowledge of cash flow, liquidity, and profit can ensure that a pharmacy owner has a clear view of their operations.

The FDA is taking action against companies that claim to treat or prevent the virus.

The law makes New Mexico the third state to enact a co-pay cap for insulin.

Regular use of fish oil dietary supplements has been linked to a lower risk of premature death and cardiovascular disease, such as heart attacks and strokes.

Levitating human plasma may lead to simpler detection of diseases and the development of addiction to substances such as opioids.

Top news from across the health care landscape.

One of the most important goals for a pharmacy owner is to optimize their gross profit per script and to navigate direct and indirect remuneration (DIR) fees through medication adherence.

Treatment with cord blood-derived chimeric antigen receptor natural killer-cell therapy targeting CD19 resulted in clinical responses in relapsed or refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.

The New Mexico House and Senate recently passed a bill that would require insurance companies to reimburse pharmacists who provide clinical services and prescribe medications.

Gilead has agreed to pay $95.50 per share in cash for Forty Seven Inc, adding the 5-year old biotechnology company to bolster its portfolio of oncology drugs.

Pharmacies can generate an average of $8800 per month from services such as consultations, educational classes, and immunizations.

Study demonstrates an association between low maternal vitamin D level in early to mid-pregnancy and an elevated risk for diagnosed attention-deficit/hyperactivity disorder in the offspring.

Antioxidant supplements do not improve fertility among men, pregnancy, or live birth rates, a study found.

A study offers evidence that chimeric antigen receptor T-cell therapy may not only extend patients’ survival, but also improve their quality of life after treatment.

AL101 is a potent, selective, injectable small molecule gamma secretase inhibitor and was granted Orphan Drug designation in May 2019 for the treatment of ACC.